Patel Purav 4
4 · REVIVA PHARMACEUTICALS HOLDINGS, INC. · Filed Apr 15, 2021
Insider Transaction Report
Form 4
Patel Purav
Director
Transactions
- Award
Stock Option (right to buy)
2021-04-14+15,227→ 15,227 totalExercise: $4.30Exp: 2031-04-13→ Common Stock, par value $0.0001 per share (15,227 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The Option will vest at the rate of twenty-five percent (25%) of the shares subject thereto upon the one year anniversary of the date of grant, and as to an additional 2.0833% of the shares on the last day of each month thereafter. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan.